AkehurstR, AndersonP, BrazierJ, BrennanA, BriggsA, BuxtonM, CairnsJ, CalvertN, ClaxtonK, DixonS, FrybackD, GallivanS, GreenC, LloydA, McCabeC, MitchellA, NichollJ, O'BrienB, RobertsJ, SculpherM, SeverensH, SullivanS, VeenstraD; Signatories to the Consensus Statement (2000).
Decision Analytic Modelling in the Economic Evaluation of Health Technologies: A Consensus Statement. Consensus Conference on Guidelines on Economic Modelling in Health Technology Assessment. PharmacoEconomics
BottomleyC, NazarethI, Torres-GonzalezF, SvabI, MaaroosHI, GeerlingsMI, XavierM, SaldiviaS, KingM (2010). Comparison of risk factors for the onset and maintenance of depression. Bristish Journal of Psychiatry
BriggsA, ClaxtonK, SchulperM (2006). Decision Modelling for Health Economic Evaluation. Oxford University Press: Oxford.
CassanoP, FavaM (2002). Depression and public health: an overview. Journal of Psychosomatic Research
CuijpersP, van StratenA, SmitF, MihalopoulosC, BeekmanA (2008). Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions. American Journal of Psychiatry
CurtisL (2012). Unit Costs of Health and Social Care 2011. Personal Social Services Research Unit (PSSRU), University of Kent: Canterbury.
DunnRL, DonoghueJM, OzminkowskiRJ, StephensonD, HylanTR (1999). Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. Journal of Psychopharmacology
FeenstraTL, van BaalPM, Jacobs-van der BruggenMO, HoogenveenRT, KommerGJ, BaanCA (2011). Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention. Cost Effectiveness and Resource Allocation
GoldbergDP, HuxleyP (1992). Common Mental Disorders: A Biosocial Model. Routledge: London.
HM Government (2010). Healthy Lives, Healthy People: Our Strategy for Public Health in England. The Stationery Office: Norwich.
HollinghurstS, PetersTJ, KaurS, WilesN, LewisG, KesslerD (2010). Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial. British Journal of Psychiatry
HSCIC (2011). Hospital Episode Statistics, Admitted Patient Care - England, 2010–11: Primary Diagnosis. Health and Social Care Information Centre (www.hscic.gov.uk/pubs/hesadmitted1011). Accessed 10 May 2012.
JenkinsonC, LayteR, JenkinsonD, LawrenceK, PetersenS, PaiceC, StradlingJ (1997). A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies?
Journal of Public Health Medicine
KaltenthalerE, ShackleyP, StevensK, BeverleyC, ParryG, ChilcottJ (2002). A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technology Assessment
KendrickT, PevelerR, LongworthL, BaldwinD, MooreM, ChatwinJ, ThornettA, GoddardJ, CampbellM, SmithH, BuxtonM, ThompsonC (2006). Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial. British Journal of Psychiatry
KindP, HardmanG, MacranS (1999). UK Population Norms For EQ-5D. Centre for Health Economics Discussion Paper. University of York: York, UK.
KingM, WalkerC, LevyG, BottomleyC, RoystonP, WeichS, Bellon-SaamenoJA, MorenoB, SvabI, RotarD, RifelJ, MaaroosHI, AluojaA, KaldaR, NeelemanJ, GeerlingsMI, XavierM, CarracaI, Goncalves-PereiraM, VicenteB, SaldiviaS, MelipillanR, Torres-GonzalezF, NazarethI (2008). Development and validation of an international risk prediction algorithm for episodes of major depression in general practice attendees: the PredictD study. Archives of General Psychiatry
MannR, GilbodyS, RichardsD (2009). Putting the ‘Q’ in depression QALYs: a comparison of utility using EQ-5D and SF-6D health related quality of life measures. Social Psychiatry and Psychiatric Epidemiology
MihalopoulosC, VosT, PirkisJ, SmitF, CarterR (2011). Do indicated preventive interventions for depression represent good value for money?
Australian and New Zealand Journal of Psychiatry
NICE (2008). Guide to the Methods of Technology Appraisal (reference N0515)
. National Institute for Health and Care Excellence: London, UK.
PeasgoodT, BrazierJ, PapaioannouD (2012). A Systematic Review of the Validity and Responsiveness of EQ-5D and SF-6D for Depression and Anxiety. Health Economics and Decision Science (HEDS) Discussion Paper, University of Sheffield.
PevelerR, KendrickT, BuxtonM, LongworthL, BaldwinD, MooreM, ChatwinJ, GoddardJ, ThornettA, SmithH, CampbellM, ThompsonC (2005). A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technology Assessment
9, 1–134, iii.
SmitF, WillemseG, KoopmanschapM, OnrustS, CuijpersP, BeekmanA (2006). Cost-effectiveness of preventing depression in primary care patients: randomised trial. British Journal of Psychiatry
SpekV, CuijpersP, NyklicekI, SmitsN, RiperH, KeyzerJ, PopV (2008). One-year follow-up results of a randomized controlled clinical trial on internet-based cognitive behavioural therapy for subthreshold depression in people over 50 years. Psychological Medicine
ThomasCM, MorrisS (2003). Cost of depression among adults in England in 2000. British Journal of Psychiatry
ValensteinM, VijanS, ZeberJE, BoehmK, ButtarA (2001). The cost-utility of screening for depression in primary care. Annals of Internal Medicine
van den BergM, SmitF, VosT, van BaalPH (2011). Cost-effectiveness of opportunistic screening and minimal contact psychotherapy to prevent depression in primary care patients. PLoS One
WeichS, NazarethI, MorganL, KingM (2007). Treatment of depression in primary care. Socio-economic status, clinical need and receipt of treatment. British Journal of Psychiatry